Skip to content

ACpath

Active
Private limited companyfounded 2018active for 8 yearsCanadalaan 1, 8902 Ieper, BelgiumKBO/BCE: BE 0711.992.668

From the official registers: KBO 7 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

ACpath has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €213,579 and a net result of €185,760. Equity has been stable since 2019 (±0.5% per year). Its solvency ranks better than 39% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

KBO
Status
Active since 23-10-2018 Normal situation
Legal form
Private limited company
Registered office
Canadalaan 1, 8902 Ieper
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.281.204.230 8902 Ieper, since 23-10-2018
Financial year end
31 December
Peppol
Reachable since 23-12-2025

Board and ownership

Board

Financial position

88 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
€301,339
▼ 0.8%
Turnover
≈ €470,000
estimated
Profit
€185,760
▲ 1.6%
Equity
€213,579
▲ 2.8%
Total assets
€431,449
▼ 13.7%
2025 accounts filed 12 days before the deadline
Filed on 19-07-2026at the National Bank
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Size: total assets €431,449Figures for financial year 2025 (filed on 19-07-2026)Show the evidence

Checked score

Score 2025
88 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 42% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 75+8
equity 49.5% of total assets
Liquidity 34-24
short-term debt 50.5% · cash 7.7%
Profitability 100=
return on assets 43.1%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1%lowest value 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.2%▲ +0.1 percentage points vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.4%▲ +0.2 percentage points vs 07-2025highest value 09-2025: 0.1%▼ -0.3 percentage points vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.2%▲ +0.1 percentage points vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €18,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.85 (0.92 in 2024), below 1. Short-term debt is 50.5% and cash 7.7% of total assets. 50.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 40% of them on solvency, 7% on liquidity, 80% on profitability and 43% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Size: total assets €431,449
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 19-07-2026)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
19202122232425
2019 to 2025 · latest year €213,579
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-07-2026, 12 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
12 days early
2024
28 days late
2023
39 days late
2022
30 days late
2021
31 days late
2020
27 days late
2019
31 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 25 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Financials · financial year 2025, micro format

Latest annual accounts filed

Annual accounts 2025

View at the NBB
Financial year ended
31-12-2025
Filed on
19-07-2026
Format
micro format
Reference
2026-00318932
Turnover
≈ €470,000
Estimated: probably between €420,000 and €580,000
Total assets
€431,449▼ 13.7%
2024 · €500,039
Net result
€185,760▲ 1.6%
2024 · €182,924
Working capital
-€33,404▼ 50.9%
2024 · -€22,132
Trend over the years

2021 to 2025, 5 financial years 2019 to 2025, 7 financial years

The operating result for 2025 is 1% lower than in 2024.

Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.

Operating result€241,763 2025 Net result€185,760 2025

Use the arrow keys on the chart for the figures per year.

The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio and return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2019202020212022202320242025
Operating result€273,545-€116,177▼ 57.5%€169,222▲ 45.7%€186,848▲ 10.4%€199,096▲ 6.6%€244,453▲ 22.8%€241,763▼ 1.1%
Net result€200,232-€74,887within the sector's middle half▼ 62.6%€131,024above the sector's middle half▲ 75.0%€145,087above the sector's middle half▲ 10.7%€154,064above the sector's middle half▲ 6.2%€182,924above the sector's middle half▲ 18.7%€185,760above the sector's middle half▲ 1.6%
Equity€212,632-€287,520within the sector's middle half▲ 35.2%€424,744above the sector's middle half▲ 47.7%€169,831within the sector's middle half▼ 60.0%€178,895within the sector's middle half▲ 5.3%€207,819within the sector's middle half▲ 16.2%€213,579within the sector's middle half▲ 2.8%
Total assets€890,291-€832,334above the sector's middle half▼ 6.5%€904,506above the sector's middle half▲ 8.7%€918,206above the sector's middle half▲ 1.5%€515,569within the sector's middle half▼ 43.9%€500,039within the sector's middle half▼ 3.0%€431,449within the sector's middle half▼ 13.7%
Debt€677,659-€544,814▼ 19.6%€479,762▼ 11.9%€748,375▲ 56.0%€336,674▼ 55.0%€292,220▼ 13.2%€217,870▼ 25.4%
Working capital-€320,821--€187,871below the sector's middle half▲ 41.4%€7,221below the sector's middle half-€188,201below the sector's middle half-€106,833below the sector's middle half▲ 43.2%-€22,132below the sector's middle half▲ 79.3%-€33,404below the sector's middle half▼ 50.9%
Solvency23.9%-34.5%within the sector's middle half▲ 10.7pp47.0%within the sector's middle half▲ 12.4pp18.5%below the sector's middle half▼ 28.5pp34.7%below the sector's middle half▲ 16.2pp41.6%within the sector's middle half▲ 6.9pp49.5%within the sector's middle half▲ 7.9pp
Current ratio0.49-0.63below the sector's middle half▲ 0.141.02below the sector's middle half▲ 0.380.75below the sector's middle half▼ 0.270.68below the sector's middle half▼ 0.070.92below the sector's middle half▲ 0.250.85below the sector's middle half▼ 0.08
Return on assets (ROA)22.5%-9.0%within the sector's middle half▼ 13.5pp14.5%within the sector's middle half▲ 5.5pp15.8%within the sector's middle half▲ 1.3pp29.9%within the sector's middle half▲ 14.1pp36.6%within the sector's middle half▲ 6.7pp43.1%above the sector's middle half▲ 6.5pp
above within below The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €431,449
Fixed assets €246,982 ▲ 6.5%
Current assets €184,466 ▼ 31.2%
Equity and liabilities €431,449
Equity €213,579 ▲ 2.8%
Debt €217,870 ▼ 25.4%
Debt's share of the balance-sheet total falls from 58.4% to 50.5%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€300,633▼
2024 · €302,502
Cash flow
€244,631▲
2024 · €240,974
Debt to equity
1.02▼
2024 · 1.41
ROE
87.0%▼
2024 · 88.0%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€217,870▼
2024 · €290,250
Income taxes
€55,965▼
2024 · €62,007
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Companies with the same profile, two years later

Historical observation

In July 2024, 26,972 companies had the same profile as ACpath has now. Two years later, 1.6% had gone bankrupt and 94.9% were still going.

  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.6% went bankrupt
3.4% stopped otherwise
94.9% was still going

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of ACpath itself is lower: 0.2% within 12 months. It rests on far more data about ACpath than the profile alone.

Test of the method

The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,972 companies, not a prediction for ACpath. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 45 lines

Source: Annual accounts 2025 at the NBB, filed on 19-07-2026.

Balance sheet Code20242025
Assets
Total assets20/58€500,039€431,449▼
Fixed assets21/28€231,921€246,982▲
Intangible fixed assets21€231,200€173,400▼
Tangible fixed assets22/27€721€73,582▲
Plant, machinery and equipment23-€738
Furniture and vehicles24€721€71,799▲
Other tangible fixed assets26-€1,045
Current assets29/58€268,118€184,466▼
Amounts receivable within one year40/41-€5,320
Trade receivables40-€1,090
Other amounts receivable41-€4,230
Current investments50/53€20,481€60,000▲
Cash at bank and in hand54/58€150,415€33,365▼
Deferred charges and accrued income490/1€97,222€85,781▼
Equity and liabilities
Total equity and liabilities10/49€500,039€431,449▼
Equity10/15€207,819€213,579▲
Contributions10/11€20,460€20,460=
Profit (loss) carried forward14€187,359€193,119▲
Amounts payable17/49€292,220€217,870▼
Amounts payable within one year42/48€290,250€217,870▼
Trade debts44€1,452€3,918▲
Suppliers440/4€1,452€3,918▲
Taxes, remuneration and social security45€17,007-
Taxes450/3€17,007-
Other amounts payable47/48€271,792€213,952▼
Accrued charges and deferred income492/3€1,970-
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€58,050€58,871▲
Other operating charges640/8€1,269€706▼
Gross operating margin9900€303,771€301,339▼
Operating profit (loss)9901€244,453€241,763▼
Financial income75/76B€690€220▼
Recurring financial income75€690€220▼
Financial charges65/66B€212€257▲
Recurring financial charges65€212€257▲
Profit (loss) for the period before taxes9903€244,931€241,725▼
Income taxes67/77€62,007€55,965▼
Profit (loss) for the period9904€182,924€185,760▲
Profit (loss) for the period to be appropriated9905€182,924€185,760▲
Appropriation of the result
Profit (loss) to be appropriated9906€341,359€373,119▲
Profit (loss) brought forward from the previous period14P€158,435€187,359▲
Transfer from equity791/2€1,860-
Transfer to equity691/2€1,860-
Addition to contributions691€1,860-
Profit to be distributed694/7€154,000€180,000▲
Return on contributions (dividend)694€154,000€180,000▲

The notes to these accounts have 10 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Line2019202020212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€73,928€73,771€73,732€73,693€73,565€58,050€58,871▲ 1.4%
Other operating charges640/8--€1,279€1,138€1,248€1,269€706▼ 44.4%
Gross operating margin9900€348,274€190,404€244,233€261,679€273,909€303,771€301,339▼ 0.8%
Operating profit (loss)9901€273,545€116,177€169,222€186,848€199,096€244,453€241,763▼ 1.1%
Financial income75/76B---€721€681€690€220▼ 68.2%
Recurring financial income75-€26-€721€681€690€220▼ 68.2%
Financial charges65/66B--€488€314€317€212€257▲ 21.6%
Recurring financial charges65€652€22,019€488€314€317€212€257▲ 21.6%
Profit (loss) for the period before taxes9903€272,893€94,184€168,734€187,256€199,460€244,931€241,725▼ 1.3%
Income taxes67/77€72,660€19,296€37,710€42,168€45,397€62,007€55,965▼ 9.7%
Profit (loss) for the period9904€200,232€74,887€131,024€145,087€154,064€182,924€185,760▲ 1.6%
Profit (loss) for the period to be appropriated9905€200,232€74,887€131,024€145,087€154,064€182,924€185,760▲ 1.6%
Line2019202020212022202320242025Change
Assets
Total assets20/58€890,291€832,334€904,506€918,206€515,569€500,039€431,449▼ 13.7%
Fixed assets21/28€583,731€509,960€436,229€362,536€289,970€231,921€246,982▲ 6.5%
Intangible fixed assets21€520,200€462,400€404,600€346,800€289,000€231,200€173,400▼ 25.0%
Tangible fixed assets22/27€63,531€47,560€31,629€15,736€970€721€73,582▲ 102×
Plant, machinery and equipment23------€738-
Furniture and vehicles24--€31,629€15,736€970€721€71,799▲ 100×
Other tangible fixed assets26------€1,045-
Current assets29/58€306,559€322,374€468,278€555,670€225,599€268,118€184,466▼ 31.2%
Amounts receivable within one year40/41-€1,672€2,005€1,420€965-€5,320-
Trade receivables40--€1,294€1,420€965-€1,090-
Other amounts receivable41--€712---€4,230-
Current investments50/53-€100,000€79,944€60,481€40,481€20,481€60,000▲ 193%
Cash at bank and in hand54/58€189,396€98,489€296,088€400,313€89,492€150,415€33,365▼ 77.8%
Deferred charges and accrued income490/1--€90,240€93,456€94,660€97,222€85,781▼ 11.8%
Equity and liabilities
Total equity and liabilities10/49€890,291€832,334€904,506€918,206€515,569€500,039€431,449▼ 13.7%
Equity10/15€212,632€287,520€424,744€169,831€178,895€207,819€213,579▲ 2.8%
Contributions10/11€12,400€12,400€18,600€18,600€18,600€20,460€20,460=
Capital10--€18,600€18,600----
Issued capital100--€18,600€18,600----
Reserves13€1,860€1,860€1,860€1,860€1,860---
Non-distributable reserves130/1--€1,860€1,860€1,860---
Legal reserve130--€1,860€1,860----
Reserves not available under the articles1311----€1,860---
Profit (loss) carried forward14€198,372€273,260€404,284€149,371€158,435€187,359€193,119▲ 3.1%
Amounts payable17/49€677,659€544,814€479,762€748,375€336,674€292,220€217,870▼ 25.4%
Amounts payable after more than one year17€50,278€34,570€18,706€2,685----
Financial debts170/4--€18,706€2,685----
Amounts payable within one year42/48€627,380€510,245€461,057€743,870€332,431€290,250€217,870▼ 24.9%
Current portion of amounts payable after more than one year42--€15,864€16,020€2,685---
Trade debts44€897€138€1,382€1,332€1,332€1,452€3,918▲ 170%
Suppliers440/4--€1,382€1,332€1,332€1,452€3,918▲ 170%
Taxes, remuneration and social security45--€5,710€4,096€397€17,007--
Taxes450/3--€5,710€4,096€397€17,007--
Other amounts payable47/48--€438,101€722,422€328,017€271,792€213,952▼ 21.3%
Accrued charges and deferred income492/3---€1,819€4,243€1,970--
Line2019202020212022202320242025Change
Profit (loss) for the period9904€200,232€74,887€131,024€145,087€154,064€182,924€185,760▲ 1.6%
+ Depreciation and write-downs630€73,928€73,771€73,732€73,693€73,565€58,050€58,871▲ 1.4%
Operating cash flow (approximation)€274,160€148,658€204,756€218,780€227,628€240,974€244,631▲ 1.5%
Investment in fixed assets (approximation)-€0€0€0-€999€0-€73,933-
Change in cash--€90,907€197,599€104,226-€310,821€60,923-€117,051-

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (7)
Financial year Type Filed Reference Document
31-12-2025 micro format 19-07-2026 2026-00318932 NBB
31-12-2024 micro format 28-08-2025 2025-00446431 PDF
31-12-2023 micro format 08-09-2024 2024-00460156 PDF
31-12-2022 micro format 30-08-2023 2023-00437118 PDF
31-12-2021 micro format 31-08-2022 2022-20424375 PDF
31-12-2020 micro format 27-08-2021 2021-65100189 PDF
31-12-2019 micro format 31-08-2020 2020-49600243 PDF

Comparable companies

These companies have the same main activity as ACpath: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €385,000 and €479,000, founded between 2018 and 2019.

CompanyFoundedTotal assetsEquityGross marginNet resultFinancial year
ACpath Ieper2018€431,449€213,579€301,339€185,7602025
Dr. Griet Buyck, Geriater Brugge2018€478,767€393,222€300,649€224,6222025
Medic Rémi Brugge2018€385,146€18,550€276,340€201,2172025
DR. JEROEN HUYS, ANESTHESIE-REANIMATIE Destelbergen2019€446,424€41,286€302,852€208,0582025
Dr. Reynaert MDL Overijse2018€432,508€111,742€293,636€228,0232025
Dr. Jeroen Wens Cardio Antwerpen2018€404,847€399,473€300,801€224,4072025
Dokter Kathleen Goossens, Cardiologie Sint-Katelijne-Waver2018€411,589€20,460€290,323€217,7452025

They were chosen from the 8,159 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, last change in 2023
Capoen, An
Statutory director · since 23-10-2018 · listed in the 2025 annual accounts, filed on 19-07-2026
Current

Mandate history

1 person, 1 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
Capoen, An
  • Statutory director, appointed in the act of 06-11-2023, still in office
See the board, name and registered office on a given date →

The board according to the articles of association

Board and representation

Board ruleThese rules set how the board is made up, meets and takes decisions.
“Één of meer bestuurders, natuurlijke personen of rechtspersonen, al dan niet aandeelhouder, beroep uitoefenen zonder fouten en volgens…”

Audit, dissolution and liquidation

Dissolution ruleThe articles set when and by whom the company can be dissolved.
One provision in the deed
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
One provision in the deed

Articles of association, deed of 06-11-2023 (in Dutch)

Owners and capital

Capital transactions

Capital over time
  1. 06-11-2023 Capital stated in the deed · 186 shares

Other provisions of the articles of association

Other provisionsThese rules from the articles cover subjects other than the board, the shares, the purpose and the meetings.
“Bevoegdheden van het bestuursorgaan, Artikel 15”
“Bestemming van de winst-reserves, Artikel 25”
Liquidation distribution: “Artikel 28, aanzuivering schulden, lasten, kosten of consignatie”

Articles of association, deed of 06-11-2023 (in Dutch)

Group and network

Connections & network

1 connected company
Depth

The connected companies are in the list below.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
former→

History

ACpath was incorporated on 23 October 2018.1 The registered office was moved to Zillebeke in 2025.2 Total assets fell from €890,291 in 2019 to €431,449 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 01-04-2025
  3. 3National Bank, annual accounts 2019 and 2025

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
19-07
NBB filing Annual accounts filedNBB
financial year 2025 · micro format
2025
28-08
NBB filing Annual accounts filedPDF
financial year 2024 · micro format · 28 days late
01-04
Gazette deed Registered office
Registered-office move · Director in office3 points ▸
  • Board meeting, 20-01-2025
  • Registered-office move, Canadalaan 1 te 8902 Zillebeke
  • Director in office, Capoen An (director)

Open the act in the Belgian Official Gazette

2024
31-12
Financial Equity above €200,000equity €207,819 ▲16.2%
With a profit in every financial year since 2019, equity grows to €207,819.
08-09
NBB filing Annual accounts filedPDF
financial year 2023 · micro format · 39 days late
2023
06-11
Gazette deed Amendment of the articles · Legal-form change · Resignations & appointments
Appointment: CAPOEN An Sabine Micheline (statutory director) · Power of attorney · Incorporation11 points ▸
  • Director appointment, CAPOEN An Sabine Micheline (statutory director), mentioned 2 times in the deed
  • Power of attorney, Tim Vandersteen
  • Power of attorney
  • Other provision, “al de beslissingen die voorafgaan, STEMMING” (deed in Dutch)
  • Incorporation, 19-10-2018
  • General meeting, 27-10-2023
  • Other provision, “statutenwijzigingshistoriek, ongewijzigd tot op heden” (deed in Dutch)
  • Amendment of the articles, mentioned 2 times in the deed
  • Capital conversion, “van rechtswege omgezet, artikel 39, §2, derde lid van de wet van 23-03-2019” (deed in Dutch)
  • Reserve release, “integrale opheffing statutair onbeschikbare eigen vermogensrekeningen, beschikbaar maken voor uitkering” (deed in Dutch)
  • Capital

Open the act in the Belgian Official Gazette

30-08
NBB filing Annual accounts filedPDF
financial year 2022 · micro format · 30 days late
2022
31-08
NBB filing Annual accounts filedPDF
financial year 2021 · micro format · 31 days late
2021
27-08
NBB filing Annual accounts filedPDF
financial year 2020 · micro format · 27 days late
2020
31-12
Financial Weakest financial yearnet €74,887 ▼62.6%
The net result drops to €74,887, the lowest from 2019 to 2025. It recovers the following year.
31-08
NBB filing Annual accounts filedPDF
financial year 2019 · micro format · 31 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

Register details

Identity

KBO record
Name ACpath in Dutch
Enterprise number 0711.992.668
Legal form Private limited company
Status Active, normale toestand
Founded 23-10-2018
Entity type Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 06-11-2023 (in Dutch)
Name clauseThe company operates under this name according to its articles.
ACpath
deed of 06-11-2023 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest, bij enkel besluit van het bestuursorgaan administratieve zetels, agentschappen, werkhuizen, stapelplaatsen en bijkantoren in…”
deed of 06-11-2023 (in Dutch)

Registered office and establishments

Registered office Canadalaan 1, 8902 Ieper, Belgium
Establishments 1 establishment unit since 2018

Activities

NACEBEL 2025
86220 Specialist medical practice main activity
86995 Nutrition and dietetics services

Invoicing and payment

VAT number BE 0711.992.668
E-invoicing via Peppol
Reachable via Peppol
Peppol ID 0208:0711992668
Other Peppol ID 9925:BE0711992668
Registered 23-12-2025

Follow this company and you will hear the next morning if it leaves the Peppol register.

Register as of 1 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Friday of June at 17:00
deed of 06-11-2023 (in Dutch)

The scores and ratios are Checked's own calculations, not a credit decision.

Environmental permits: No permit applications found in Flanders.

Sites & property

Location
registered office establishment The establishment unit on the map
1 establishment unit
ACpath
Canadalaan 1, 8902 IeperSpecialist medical practice
since 2018unit number 2.281.204.230

Buildings and parcels at the address

Ground area
3,588 m²
Building footprint
294 m²
Building volume
859 m³
Parcel 33036B0014/00M000, Flanders · tallest building 9.0 m.
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
33036B0014/00M000 Flanders 3,588 m² 1 · 294 m² 9.0 m · 1